|
GENERAL NUTRITION COMPANIES INC - S-4/A - 20040809 - BUSINESS
BUSINESS
General Nutrition Centers, Inc.
We are the largest global specialty retailer of
nutritional supplements, which include sports nutrition
products, diet products, vitamins, minerals and herbal
supplements (VMHS) and specialty supplements. We derive our
revenues principally from product sales through our
company-owned stores, franchise activities and sales of products
manufactured in our facilities to third parties. On
December 5, 2003, we acquired from Numico USA, Inc., 100%
of the outstanding equity interests of General Nutrition
Companies, Inc., a company that opened its first health food
store in 1935 and today sells products through a worldwide
network of more than 5,600 locations operating under the GNC
brand name. According to the 2003 Gallup Survey of Vitamin
Users, the GNC brand name is one of the most widely recognized
brands in the nutritional supplements industry. An estimated 84%
of the U.S. population recognizes GNC as a source of health and
wellness products based on the Parker 2003 Awareness Study. Our
product mix, which is focused on high-margin, value-added
nutritional products, is sold under our GNC proprietary brands,
including Mega Men, Pro Performance, Total Lean and
Preventive Nutrition, and under nationally recognized
third-party brands, including Muscletech, EAS and Atkins.
The following charts illustrate, for the twelve
months ended June 30, 2004, the percentage of our net
revenues generated by our three business segments and the
percentage of our net U.S. retail supplement revenues generated
by our four product categories:
|
|
|
|
|
Net Revenues By Segment
|
|
Net U.S. Retail Revenues
By Product Category
|
|
|
|
|
Business Overview
Retail Locations
Our retail network represents the largest
specialty retail store network in the nutritional supplements
industry according to the NBJ 2003 Supplement Report. As of
June 30, 2004, there were 4,974 GNC locations in the United
States and Canada and 692 franchised stores operating in
other international locations under the GNC name. Of our U.S.
and Canadian locations, 2,649 were company-owned stores, 1,331
were franchised stores and 994 were GNC store-within-a-store
locations under our strategic alliance with Rite Aid. Our retail
network in the United States was approximately eight times
larger than that of our nearest specialty retail competitor as
of June 30, 2004. Most of our U.S. stores are between 1,000
and 2,000 square feet and are located in shopping malls and
strip shopping centers. In the fourth quarter of 2002, we
completed a store reset and upgrade program. As a result, many
of our stores have a modern and customer-friendly layout and
promote our GNC Live Well theme.
Franchise Activities
As of June 30, 2004, we had 1,331 franchised
stores in the United States and Canada and 692 other
international franchised stores. We generate income from
franchise activities primarily through product sales to
franchisees, royalties on franchise retail sales and franchise
fees. To assist our franchisees in the successful
58
operation of their stores and to protect our
brand image, we offer a number of services to franchisees
including training, site selection, construction assistance and
accounting services. We believe that our franchise program
enhances our brand awareness and market presence and will enable
us to expand our store base internationally with minimal capital
expenditures by us. We enjoy strong relationships with our
franchisees, as evidenced by our franchisee renewal rate of over
98% between 2000 and 2003. Our franchise program has been
recognized numerous times by several publications as one of the
top franchise programs in the country.
Store-Within-a-Store
Locations
To increase brand awareness and promote access to
customers who may not frequent specialty nutrition stores, we
entered into a strategic alliance with Rite Aid to open our GNC
store-within-a-store locations. As of June 30, 2004, we had
994 store-within-a-store locations. Through this strategic
alliance, we generate revenues from sales to Rite Aid of our
products at wholesale prices, the manufacture of Rite Aid
private label products and retail sales of consignment
inventory. We are Rite Aids sole supplier for the
PharmAssure® vitamin brand and a number of Rite Aid private
label supplements. We recently extended our alliance with Rite
Aid through April 30, 2009, with its commitment to open 300
new store-within-a-store locations by December 31, 2006.
Products
We offer a wide range of nutritional supplements
sold under our GNC proprietary brand names, including Mega Men,
Pro Performance, Total Lean and Preventive Nutrition, and under
nationally recognized third-party brand names, including
Muscletech, EAS and Atkins. Sales of our proprietary brands at
our company-owned stores represented approximately 42% of our
net retail product revenues for the twelve months ended
June 30, 2004. We generally have higher gross margins on
sales of our proprietary brands than on sales of third-party
brands. We develop our proprietary products independently at our
own facilities and through collaborative efforts with our
suppliers. In addition, we have arrangements with several of our
suppliers that enable us to be the preferred distributor of a
number of third-party products. We believe that new products are
a key driver of customer traffic and purchases, and we are
committed to developing new and innovative products for the
nutritional supplements industry. We launched 37 new
products during the year ended December 31, 2003. During
the six months ended June 30, 2004, we launched 33 new
products, and we expect to launch 60 additional new
products during the remainder of 2004.
Marketing
We market our proprietary brands of nutritional
products through an integrated marketing program that includes
television, print and radio media, storefront graphics, direct
mailings to members of our Gold Card program and point of
purchase materials. Our Gold Card program is a key component of
our marketing strategy and entitles members to discount offers
and other benefits. With 4.5 million Gold Card members as
of June 30, 2004, we believe that our Gold Card program
builds customer loyalty and serves to make us a destination
retailer. We also benefit from product advertising paid for
entirely by third-party vendors, which promotes their products
and identifies our locations as a place to purchase their
products.
Manufacturing and
Distribution
With our technologically sophisticated
manufacturing and distribution facilities supporting our retail
stores, we are a low-cost, vertically integrated producer and
supplier of nutritional supplements. We operate two
manufacturing facilities in South Carolina and three
distribution centers located in Pennsylvania, South Carolina and
Arizona. Although we utilize our facilities primarily for the
production of our proprietary products that are sold at GNC
locations, we have available capacity to produce products for
sale to third-party customers. By controlling the production and
distribution of our proprietary products, we believe we can
better control costs, protect product quality, monitor delivery
times and maintain appropriate inventory levels.
59
Industry Overview
The U.S. nutritional supplements retail industry,
which includes nutritional supplements sold through all
channels, is large and highly fragmented, with no single
industry participant accounting for more than 10% of total
industry retail sales in 2002, the most recent period for which
information is available. Participants include specialty
retailers, supermarkets, drugstores, mass merchants, multi-level
marketing organizations, mail order companies and a variety of
other smaller participants. The nutritional supplements sold
through these channels are divided into four major product
categories: sports nutrition products, diet products, VMHS and
specialty supplements. Most supermarkets, drugstores and mass
merchants have narrow nutritional supplement product offerings
limited primarily to simple vitamins and herbs, with less
knowledgeable sales associates than specialty retailers. We
believe that these merchants share of the nutritional
supplements market over the last five years has remained
relatively constant.
During the 1990s, our industry underwent a period
of rapid expansion. From 1990 to 2002, industry retail sales
grew at a compound annual growth rate of 10.0%, with the most
rapid growth in the early 1990s. According to the NBJ 2003
Supplement Report, total industry sales in the United States
were approximately $18.8 billion in 2002 and were estimated
to grow at a compound annual growth rate of 3.7% from 2002
through 2008. Several demographic, healthcare and lifestyle
trends are expected to drive the continued growth of the
nutritional supplements industry. These trends include:
|
|
|
|
|
|
|
Aging Population:
The average age of the U.S. population
is increasing. U.S. Census Bureau data indicates that the number
of Americans age 55 or older is expected to increase by 19% from
2003 to 2010. We believe that consumers over the age of 55 are
significantly more likely to use VMHS products than younger
persons.
|
|
|
|
|
|
Rising Healthcare Costs and Use of Preventive
Measures:
Healthcare related costs
have increased substantially in the United States. According to
a leading healthcare provider, private health insurance premiums
increased an average of 13.9% from 2002 to 2003. To reduce
medical costs and avoid the complexities of dealing with the
healthcare system, many consumers take preventive measures,
including alternative medicines and nutritional supplements.
|
|
|
|
|
|
Increasing Focus on Fitness:
The number of Americans belonging to
health clubs has grown 23% from 29.5 million in 1998 to
36.3 million in 2002, according to the most recent trend
report published by the International Health, Racquet &
Sportsclub Association. We believe that fitness-oriented
consumers are interested in taking sports nutrition products to
increase energy, endurance and strength during exercise.
|
|
|
|
|
|
Increasing Incidence of Obesity:
According to a 2002 study by the
National Heart, Lung and Blood Institute, 61% of adults ages
20-74 in the United States are either overweight or obese.
Obesity may lead to more serious health conditions, such as
diabetes, heart disease and high blood pressure. An estimated
46% of adults in the United States are dieting, according to a
2003 Gallup Study of Dieting and the Market for Diet Products
and Services.
|
According to the NBJ 2003 Supplement Report,
total global industry sales were approximately
$50.0 billion in 2001, the most recent period for which
international information is available. The largest markets were
the United States at $18.1 billion, followed by Europe at
$14.5 billion and Asia with $13.4 billion.
Competitive Strengths
We believe we are well positioned to capitalize
on the emerging demographic, healthcare and lifestyle trends
affecting our industry and to grow our revenues due to the
following competitive strengths:
Unmatched Specialty Retail Footprint.
Our retail network in the United
States was approximately eight times larger than that of our
nearest specialty retail competitor as of June 30, 2004.
The size of our retail network provides us with advantages
within the fragmented nutritional supplements industry. For
instance, our scale helps us to attract industry-leading vendors
to sell their products in our locations, often on a preferred
60
basis. Our extensive retail footprint in
established territories also provides us with broad distribution
capabilities that we believe are difficult for our competitors
to replicate without significant time and cost. Through our
multiple store formats located across the United States, large
franchise operations and extensive international store base, we
are not dependent on any single store format or geographic
location.
Strong Brand Recognition and Customer Loyalty.
We have strong brand recognition
within the nutritional supplements industry. According to the
Parker 2003 Parker Awareness Study, an estimated 84% of the U.S.
population recognizes the GNC brand name as a source of health
and wellness products. We utilize extensive marketing and
advertising campaigns through television, print and radio media,
storefront graphics, Gold Card membership communications and
point of purchase materials to strengthen and reinforce our
brand recognition. Our Gold Card program cultivates customer
loyalty through a combination of discount offers and targeted
marketing efforts. We believe that our Gold Card program helps
to make us a destination retailer.
Ability to Leverage Existing Retail
Infrastructure.
Our incremental retail
sales result in disproportionate increases in operating income
as we leverage the largely fixed cost nature of our retail
operations and our high retail gross product margins. Our
existing store base, stable size of our workforce and
established distribution network can support higher sales volume
without adding significant incremental costs and enable us to
convert a high percentage of our net revenues into cash flow
from operations.
Extensive Product Selection.
We offer an extensive mix of brands
and products, including approximately 2,200 stock keeping units
(SKUs) across multiple categories. This variety
provides our customers with a wide selection of products to fit
their specific needs and provides us with an advantage over
drugstores, supermarkets and mass merchants who offer a more
limited product selection. Our products include powders, bars,
tablets, meal replacements, shakes and teas. With a broad range
of products, our success does not depend on any one specific
product or vendor. During the twelve months ended June 30,
2004, no single product accounted for more than 4.6% of our
company-owned store sales.
New Product Development.
We believe that new products are a key
driver of customer traffic and purchases. Interactions with our
customers and raw materials vendors help us identify changes in
consumer trends that, in turn, influence our development,
manufacturing and marketing of new products. In March 2003, we
integrated and upgraded our previously decentralized product
development function, creating dedicated development teams that
conduct extensive market research and use scientific methods and
third-party product testing to formulate new value-added
products geared to specific nutritional concerns, such as heart
health, digestive function and womens health issues. This
initiative has led to a meaningful increase in new product
development activity. We launched 37 new products during the
year ended December 31, 2003. During the six months ended
June 30, 2004, we launched 33 new products, and we expect
to launch 60 additional new products during the remainder
of 2004.
Value-Added Customer Service.
Our sales associates are trained to
provide guidance to customers with respect to the broad
selection of products sold in our stores. We believe this level
of customer service provides us with an advantage over
supermarkets, drugstores and mass merchants. We provide ongoing
training to our sales associates to ensure that they are
prepared to educate customers about product features and direct
them to products that will address their specific requests. In
2002, we instituted the GNC University, an online
training program for our sales associates at our company-owned
stores and for sales associates at participating franchised
locations. We provide additional education and training
materials through a monthly newsletter detailing new products
and through interactive training modules. We also provide a wide
range of nutritional information in numerous forms, including
signage, brochures, and touch screen computers enabling
customers to make informed purchases.
Vertically Integrated Operational
Capabilities.
Our vertically
integrated manufacturing, distribution and retail capabilities
differentiate us from many of our competitors. We believe our
technologically sophisticated manufacturing facilities and
distribution centers, combined with our retail footprint, enable
us to better control costs and protect product quality. We are
also better able to monitor delivery times and to maintain
appropriate inventory levels for our proprietary products by
controlling production scheduling and distribution.
61
Experienced Management
Team.
Our senior management team is
comprised of experienced retail executives who have on average
been employed with us for over 14 years. As of
June 30, 2004, our senior management and our directors
owned approximately 2.3%, in the aggregate, and had options to
purchase an additional 5.6%, in the aggregate, of the fully
diluted common equity of our parent company. In addition, our
board of directors is comprised of executives with significant
experience in the retail industry.
Business Strategy
As the largest global specialty retailer of
nutritional supplements, our goal is to further capitalize on
the trends affecting our industry by pursuing the following
initiatives:
|
|
|
|
|
|
|
continue to obtain additional third-party
preferred distributor arrangements and position ourselves to be
first-to-market with new and innovative products by partnering
with our suppliers and leveraging our extensive specialty retail
footprint. We intend to offer distributors additional
opportunities to place preferred products in highly visible
merchandising locations within the store, as well as including
these products in our monthly direct marketing communications to
our Gold Card customers as a means of expanding our preferred
distributor arrangements.
|
|
|
|
|
|
continue to formulate new value-added products
and shift our product mix to emphasize our proprietary products,
which typically have higher gross product margins, by utilizing
our integrated product development capabilities and featuring
our proprietary products through our in-store merchandising.
|
|
|
|
|
|
encourage customer loyalty, facilitate direct
marketing, and increase cross-selling and up-selling
opportunities by using our extensive Gold Card customer
database. Our database of Gold Card members allows us to execute
extensive direct marketing activities. We are focused on
increasing cross-selling and up-selling opportunities by
analyzing customer buying patterns in greater detail and using
this data to distribute targeted direct marketing materials to
specific customer groups. We intend to develop additional
loyalty programs focused on building strong, long-term, value
added relationships with our best customers to further
strengthen their loyalty to the GNC brand.
|
|
|
|
|
|
expand our international store network by growing
our international franchise presence, which requires minimal
capital expenditures by us. We intend to continue our policy of
awarding franchising rights within a country to well-capitalized
franchisees that will, together with us, determine future year
commitments for stores and product distribution in that country
and annually review the potential for new locations. We
currently have 488 international stores scheduled to be
opened in the next three years under existing development
agreements.
|
|
|
|
|
|
produce products for sale to third-party retail
and wholesale customers to better utilize our available
manufacturing capacity. We intend to continue to actively pursue
these customers with competitive pricing that will enhance our
sales and better utilize our current excess manufacturing
capacity.
|
|
|
|
|
|
reduce our debt by using excess cash flow not
otherwise needed in our business or for the execution of our
business strategies, as appropriate.
|
Company History
We are a wholly owned subsidiary and an operating
company of GNC Corporation, our parent. We were formed as a
Delaware corporation in October 2003 by Apollo
Management V, L.P., an affiliate of Apollo and certain
members of our management, to acquire General Nutrition
Companies, Inc. (GNCI) from Numico USA, Inc.
(Numico USA). GNCI was acquired in August 1999 by
Numico Investment Corp. (NIC) which, subsequent to
the acquisition, was merged into GNCI. NIC was a wholly owned
subsidiary of an entity ultimately merged into Numico USA.
Numico USA is a wholly owned subsidiary of Koninklijke (Royal)
Numico N.V. (together with Numico USA, Numico), a
Dutch public company. Prior to the acquisition by NIC in 1999,
GNCI was a publicly traded company, listed on the Nasdaq
National Market.
62
On December 5, 2003, we purchased 100% of
the outstanding equity interests of GNCI. Simultaneously with
the closing of the Acquisition, we entered into a new senior
credit facility with a syndicate of lenders, consisting of a
term loan facility and a revolving credit facility. We borrowed
the full amount of the term loan facility to fund a portion of
the Acquisition purchase price, but made no borrowings under the
revolving credit facility. Our obligations under the senior
credit facility are guaranteed by our parent company and our
domestic subsidiaries. See Description of Senior Credit
Facility for a more detailed description of our senior
credit facility. We also used the net proceeds from the offering
of the old notes to fund a portion of the Acquisition purchase
price. In addition, our parent received an equity contribution
in exchange for its common and preferred stock from
GNC Investors, LLC, its principal stockholder, which we
refer to in this prospectus as our equity sponsor. Our parent
contributed the full amount of the equity contribution to us to
fund a portion of the Acquisition purchase price. Our equity
sponsor subsequently resold all of our preferred stock to other
institutional investors.
Our equity sponsor held approximately 96% of our
parents outstanding common stock as of June 30, 2004.
Affiliates of Apollo Advisors V, L.P. (Apollo
Advisors V) and other institutional investors own all
of the equity interests of our equity sponsor, with affiliates
of Apollo Advisors V owing approximately 76% of such
equity interests.
Business Segments
We generate revenues primarily from our three
business segments, Retail, Franchise and Manufacturing/
Wholesale. The following chart outlines our business segments
and the historical contribution to our consolidated revenues by
those segments, after intercompany eliminations. For a
description of operating income (loss) by business segment,
our total assets by business segment, total revenues by
geographic area, and total assets by geographic area, see note
23 to our consolidated financial statements included elsewhere
in this prospectus.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor
|
|
Successor
|
|
Predecessor
|
|
Successor
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Period from
|
|
|
|
Six
|
|
Six
|
|
|
|
|
|
January 1, 2003
|
|
27 Days
|
|
Months
|
|
Months
|
|
|
|
|
|
to
|
|
Ended
|
|
Ended
|
|
Ended
|
|
|
|
Year Ended December 31,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 4,
|
|
December 31,
|
|
June 30,
|
|
June 30,
|
|
(dollars in millions)
|
|
2001
|
|
2002
|
|
2003
|
|
2003
|
|
2003
|
|
2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail
|
|
$
|
1,123.1
|
|
|
|
74.4
|
%
|
|
$
|
1,068.6
|
|
|
|
75.0
|
%
|
|
$
|
993.3
|
|
|
|
74.1
|
%
|
|
$
|
66.2
|
|
|
|
74.1
|
%
|
|
$
|
543.2
|
|
|
|
75.1
|
%
|
|
$
|
541.0
|
|
|
|
75.1
|
%
|
|
Franchise
|
|
|
273.1
|
|
|
|
18.1
|
|
|
|
256.1
|
|
|
|
18.0
|
|
|
|
241.3
|
|
|
|
18.0
|
|
|
|
14.2
|
|
|
|
15.9
|
|
|
|
128.1
|
|
|
|
17.7
|
|
|
|
123.0
|
|
|
|
17.1
|
|
|
Manufacturing/ Wholesale
|
|
|
112.9
|
|
|
|
7.5
|
|
|
|
100.3
|
|
|
|
7.0
|
|
|
|
105.6
|
|
|
|
7.9
|
|
|
|
8.9
|
|
|
|
10.0
|
|
|
|
51.9
|
|
|
|
7.2
|
|
|
|
56.3
|
|
|
|
7.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,509.1
|
|
|
|
100.0
|
%
|
|
$
|
1,425.0
|
|
|
|
100.0
|
%
|
|
$
|
1,340.2
|
|
|
|
100.0
|
%
|
|
$
|
89.3
|
|
|
|
100.0
|
%
|
|
$
|
723.2
|
|
|
|
100.0%
|
|
|
$
|
720.3
|
|
|
|
100.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail
Our Retail segment generates revenues from sales
of products to customers at our company-owned stores in the
United States and Canada.
Locations
As of June 30, 2004, we operated 2,649
company-owned stores across 50 states and in Canada, Puerto
Rico and Washington DC. Most of our U.S. company-owned stores
are between 1,000 and 2,000 square feet and are located
primarily in shopping malls and strip shopping centers.
Traditional mall and strip mall locations typically generate a
large percentage of our total retail sales. All of our
company-owned stores follow one of two consistent formats, one
for mall locations and one for strip shopping center locations.
Our store graphics are periodically redesigned to better
identify with our GNC customers and provide product information
to allow the consumer to make educated decisions regarding
product purchases and usage. Our product labeling is consistent
within our product lines and the stores are designed to present
a unified approach to packaging with emphasis on added
information for the consumer. In addition, in the fourth quarter
of 2002 we completed a store reset and upgrade program for all
of our company-owned stores to create a more modern and
customer-friendly layout, while promoting our GNC Live Well
theme. As part of the store reset and upgrade program, we
redesigned our floor layouts to create one-stop stations where
our customers can locate a variety of products to address their
specific needs.
63
Products
We offer a wide range of nutritional supplements
sold under our GNC proprietary brand names, including, Mega Men,
Pro Performance, Total Lean and Preventive Nutrition, and under
nationally recognized third-party brand names, including
Muscletech, EAS and Atkins. We operate in four major nutritional
supplement categories: sports nutrition products, diet products,
VMHS and specialty supplements. We offer an extensive mix of
brands and products, including approximately 2,200 SKUs across
multiple categories. This variety is designed to provide our
customers with a vast selection of products to fit their
specific needs. Sales of our proprietary brands at our
company-owned stores represented approximately 42% of our net
retail product revenues for the twelve months ended
June 30, 2004.
Products are delivered to our retail stores
through our distribution operations located in Leetsdale,
Pennsylvania; Anderson, South Carolina; and Phoenix, Arizona.
Our distribution centers support our company-owned stores as
well as franchised stores and Rite Aid locations. Our
distribution fleet delivers raw materials and components to our
manufacturing facilities and delivers our finished goods and
third-party products through our distribution centers to our
company-owned and domestic franchised stores on a weekly and
biweekly basis, depending on sales volume of the store. Each of
our distribution centers has a quality control department that
monitors products received from our vendors to determine if they
meet our requirements.
Based on data collected from our point of sale
systems (POS), below is a comparison of our domestic retail
product sales by major product category and the respective
percentage of our retail supplement sales for the period shown:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
Six Months
|
|
Six Months
|
|
|
|
|
|
Ended
|
|
Ended
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
June 30,
|
|
|
|
2001
|
|
2002
|
|
2003(1)
|
|
2003
|
|
2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sports Nutrition Products
|
|
|
287.5
|
|
|
|
26.5
|
%
|
|
|
288.7
|
|
|
|
28.1
|
%
|
|
|
300.9
|
|
|
|
29.8
|
%
|
|
|
158.7
|
|
|
|
32.0
|
%
|
|
|
160.3
|
|
|
|
33.0
|
%
|
|
Diet Products
|
|
|
289.2
|
|
|
|
26.7
|
%
|
|
|
267.1
|
|
|
|
26.0
|
%
|
|
|
265.6
|
|
|
|
26.3
|
%
|
|
|
141.5
|
|
|
|
28.6
|
%
|
|
|
115.9
|
|
|
|
23.8
|
%
|
|
VMHS
|
|
|
273.1
|
|
|
|
25.2
|
%
|
|
|
252.8
|
|
|
|
24.6
|
%
|
|
|
238.4
|
|
|
|
23.6
|
%
|
|
|
122.4
|
|
|
|
24.7
|
%
|
|
|
124.0
|
|
|
|
25.5
|
%
|
|
Specialty Supplements
|
|
|
148.9
|
|
|
|
13.7
|
%
|
|
|
139.8
|
|
|
|
13.6
|
%
|
|
|
126.6
|
|
|
|
12.5
|
%
|
|
|
63.4
|
|
|
|
12.8
|
%
|
|
|
63.5
|
|
|
|
13.1
|
%
|
|
Other
|
|
|
85.0
|
|
|
|
7.8
|
%
|
|
|
77.8
|
|
|
|
7.6
|
%
|
|
|
78.4
|
|
|
|
7.8
|
%
|
|
|
9.5
|
|
|
|
1.9
|
%
|
|
|
22.5
|
|
|
|
4.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,083.7
|
|
|
|
100.0
|
%
|
|
|
1,026.2
|
|
|
|
100.0
|
%
|
|
|
1,009.9
|
|
|
|
100.0
|
%
|
|
|
495.5
|
|
|
|
100.0
|
%
|
|
|
486.2
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
2003 data calculated on a combined basis, by
adding data for the period from January 1, 2003 through
December 4, 2003 to data for the 27 days ended
December 31, 2003.
|
Sports Nutrition Products
Sports nutrition products are designed to be
taken in conjunction with an exercise and fitness regimen. Our
target consumer for sports nutrition products is the
18-49 year old male. We typically offer a broad selection
of sports nutrition products, such as protein and weight gain
powders, sports drinks, sports bars, and high potency vitamin
formulations, including GNC brands such as Pro Performance and
popular third-party products such as NO2®.
Diet Products
Diet products consist of various formulas
designed to supplement the diet and exercise plans of weight
conscious consumers. Our target consumer for diet products is
the 18-49 year old female. We typically offer a variety of
diet products, including pills, meal replacements, shakes, diet
bars and teas. Our retail stores offer our proprietary and
third-party products suitable for different diet and weight
management approaches, including low-carbohydrate products and
products designed to increase thermogenesis (a change in the
bodys metabolic rate measured in terms of calories) and
metabolism. We also offer several ephedra-free diet products,
including our Total Lean and our Body Answers product
lines.
64
VMHS
We sell vitamins and minerals in single nutrient
and multi-nutrient form and in different potency levels. Our
vitamin and mineral products are available in tablets, soft
gelatin and hard-shell capsules and powder forms. Many of our
special vitamin and mineral formulations, such as Mega Men®
and Ultra Mega®, are only available at GNC locations. In
addition to our selection of VMHS products with unique
formulations, we also offer the full range of standard
alphabet vitamins. We sell herbal supplements in
various solid dosage and soft gelatin capsules, tea and liquid
forms. We have consolidated our traditional herbal offerings
under a single umbrella brand, Herbal Plus®. In addition to
the Herbal Plus line, we offer a full line of whole food-based
supplements and top selling herb and natural remedy products.
Our target consumers for VMHS are women over the age of 35.
Specialty Supplements
Specialty supplements is a catch-all category for
nutritional supplements that do not fit within the bounds of the
other nutritional supplement categories. Specialty supplements
products containing glucosamine (a sugar produced in the body
that is involved in the formation of cartilage, ligaments,
tendons, bones, eyes, nails and heart valves) and melatonin (a
hormone linked to regulation of the bodys sleep-wake
cycle), as well as products that are designed to provide
nutritional support to specific areas of the body. Our target
consumers for specialty supplements are women over the age of
35. Many of our specialty supplements have ingredients unique to
our formulations that are not available at other outlets. Our
specialty supplements particularly emphasize recent third party
research and available literature regarding the positive
benefits from certain ingredients. Our comprehensive Preventive
Nutrition product line includes Heart Advance, a product
designed to support healthy heart and blood vessel function,
Triple Cleanse, a product designed to support healthy
digestive function, and Fast Flex, a product designed to provide
comprehensive joint support. Our specialty supplements are
located in designated wall areas that include information and
other products that offer a comprehensive solution to meet a
customers particular nutritional concerns.
Product Development
We believe a key driver of customer traffic and
purchases is the introduction of new products. According to the
Parker 2003 Awareness Study, 49% of consumers surveyed rated the
availability of new, innovative products as
extremely or very important when making purchase decisions and
rated this as one of our competitive strengths. We identify
changing customer trends through interactions with our customers
and leading industry vendors to assist in the development,
manufacturing and marketing of our new products. We develop
proprietary products independently and through the collaborative
effort of our dedicated development team. During 2003, we
targeted our product development efforts on sports nutrition
products, diverse diet products and specialty supplements,
including ephedra-free and low-carbohydrate weight management
products and new sports formulas and delivery systems. We
launched 37 new products during the year ended December 31,
2003. During the six months ended June 30, 2004, we
launched 33 new products, and we expect to launch 60 additional
new products during the remainder of 2004.
Franchise
Our Franchise segment is comprised of our
domestic and international franchise operations. Our Franchise
segment generates revenues from franchise activities primarily
through product sales to franchisees, royalties on franchise
retail sales and franchise fees.
As a means of enhancing our operating performance
and building our store base, we began opening franchised
locations in 1988. As of June 30, 2004, there were 2,023
franchised stores operating, including 1,331 stores in the
United States and Canada and 692 stores operating in other
international locations. Approximately 88% of our franchises in
the United States as of June 30, 2004 were in strip mall
shopping centers and are typically between 1,200 and 1,800
square feet. The international franchised stores are smaller,
typically an average of 750 square feet and, depending upon the
country and cultural preferences, are located in mall, strip
mall shopping center, street or store-within-a-store locations.
All of our franchised stores in the
65
United States were recently reset in the same
manner as our company-owned stores. Typically, our international
stores have a store format and signage similar to our U.S.
franchised stores. To assist our franchisees in the successful
operation of their stores and to protect our brand image, we
offer site selection, construction assistance, accounting
services and a three-part training program, which consists of
classroom instruction, training in a company-owned location and
actual on-site training after the franchised store opens. We
enjoy strong relationships with our franchisees, as evidenced by
our franchisee renewal rate of over 98% between 2000 and 2003.
In addition, we do not have heavy reliance on any single
franchise operator in the United States, as the largest
franchisee owns and/or operates 11 store locations.
All of our franchised stores in the United States
offer both our proprietary products and third-party products,
with a product selection similar to that of our company-owned
stores. Our international franchised stores offer a more limited
product selection than our franchised stores in the United
States. Products are distributed to our franchised stores in the
United States through our distribution centers and
transportation fleet in the same manner as our company-owned
stores.
Franchises in the United
States
Franchise revenues from our franchisees in the
United States accounted for approximately 84% of our franchise
revenues for the twelve months ended June 30, 2004. In
2004, new franchisees in the United States are required to pay
an initial fee of $40,000 for a franchise license. Existing GNC
franchise operators may purchase an additional franchise license
for a fee of $30,000. We typically offer limited financing to
qualified franchisees in the United States for terms up to five
years. Once a store is established, franchisees are required to
pay us a continuing royalty of 6% of sales and contribute 3% of
sales to a national advertising fund. Our standard franchise
agreements for the United States are effective for a ten-year
period with two five-year renewal options. At the end of the
initial term and each of the renewal periods, the renewal fee is
33% of the franchisee fee that is then in effect. The franchise
renewal option is at our election for all franchise agreements
executed after December 1995. Our franchisees in the United
States receive limited geographical exclusivity and are required
to follow the GNC store format.
Franchisees must meet certain minimum standards
and duties prescribed by our franchise operations manual and we
conduct periodic field visit reports to ensure our minimum
standards are maintained. Generally, we enter into a five-year
lease with two five-year renewal options with landlords for our
franchised locations in the United States. This allows us to
secure space at cost-effective rates, which we sublease to our
franchisees at cost. By subleasing to our franchisees, we have
greater control over the location and have greater bargaining
power for lease negotiations than an individual franchisee
typically would have, and we can elect not to renew subleases
for underperforming locations. If a franchisee does not meet
specified performance and appearance criteria, the franchise
agreement specifies the procedures under which we are permitted
to terminate the franchise agreement. In these situations, we
may take possession of the location, inventory, and equipment,
and operate the store as a company-owned store or re-franchise
the location. Our U.S. franchise agreements and operations in
the United States are regulated by the FTC. See
Government Regulation Franchise Regulation.
International Franchises
Franchise revenues from our international
franchisees accounted for approximately 16% of our franchise
revenues for the twelve months ended June 30, 2004. In
2004, new international franchisees were required to pay an
initial fee of $20,000 for a franchise license for each store
and continuing royalty fees of 5% of sales. Our franchise
program has enabled us to expand into international markets with
limited capital expenditures. We expanded our international
presence from 457 international franchised locations at the end
of 2001 to 692 international locations as of June 30, 2004,
without incurring any capital expenditures related to such
expansion. Our international franchised stores generate sales
per square foot of store space comparable to domestic store
locations. However, we typically generate less revenues from
franchises outside the United States due to lower international
royalty rates and a smaller percentage of products that are
purchased by the franchisees from us.
66
Franchisees in international locations enter into
development agreements with us for either full size stores or a
store-within-a-store at a host location. The development
agreement grants the franchisee the right to develop a specific
number of stores in a territory, often an entire country. The
international franchisee then enters into a franchise agreement
for each location. The full-size store franchise agreement has
an initial ten-year term with two five-year renewal options. At
the end of the initial term and each of the renewal periods, the
international franchisee has the option to renew the agreement
at 33% of the franchise fee that is then in effect. Franchise
agreements for international store-within-a-store locations have
an initial term of five years, with two five-year renewal
options. At the end of the initial term and each of the renewal
periods, the international franchisee of a store-within-a-store
location has the option to renew the agreement for 50% of the
franchise fee that is then in effect. Our international
franchisees often receive exclusive franchising rights to the
entire country franchised, excluding military bases. Our
international franchisee must meet minimum standards and duties
similar to our U.S. franchisees and our international franchise
agreements and international operations may be regulated by
various state, local and international laws. See
Government Regulation Franchise Regulation.
Manufacturing/ Wholesale
Our Manufacturing/ Wholesale segment is comprised
of our manufacturing operations in South Carolina and our
wholesale sales business. This segment supplies our Retail and
Franchise segments as well as various third parties with
finished products. Our Manufacturing/ Wholesale segment
generates revenues through sales of manufactured products to
third parties, generally for third-party private label brands,
and the sale of our proprietary and third-party brand products
to Rite Aid and drugstore.com.
Manufacturing
Our technologically sophisticated manufacturing
and distribution facilities support our Retail and Franchise
segments and enable us to control the production and
distribution of our proprietary products, better control costs,
protect product quality, monitor delivery times and maintain
appropriate inventory levels. We operate two main manufacturing
facilities, one in Greenville, South Carolina and one in
Anderson, South Carolina. We utilize our plants primarily for
the production of proprietary products. Our manufacturing
operations are designed to allow low- cost production of a
variety of products of different quantities, sizes and packaging
configurations while maintaining strict levels of quality
control. Our manufacturing procedures are designed to promote
consistency and quality in our finished goods. We conduct sample
testing on raw materials and finished products, including
weight, purity and microbiological testing. Our manufacturing
facilities also service our wholesale operations, including the
manufacture and supply of Rite Aid private label products for
distribution to Rite Aid locations. We also use our available
capacity at these facilities to produce products for sale to
third-party customers. Our distribution fleet delivers raw
materials and components to our manufacturing facilities and
delivers our finished goods and third-party products to our
distribution centers.
The principal raw materials used in the
manufacturing process are natural and synthetic vitamins, herbs,
minerals, and gelatin. We maintain multiple sources for the
majority of our raw materials, with the remaining being single
sourced due to the uniqueness of the material. As of
December 31, 2003, no one vendor supplied more than 7% of
our raw materials. In the event any of our third-party suppliers
or vendors were to become unable or unwilling to continue to
provide raw materials and third-party products in the required
volumes and quality levels or in a timely manner, we would be
required to identify and obtain acceptable replacement supply
sources. If we are unable to obtain alternative suppliers, our
business could be adversely affected.
Wholesale
Store-Within-a-Store Locations
To increase brand awareness and promote access to
customers who may not frequent specialty nutrition stores, we
entered into a strategic alliance with Rite Aid to open GNC
store-within-a-store locations. As of
67
June 30, 2004, we had 994
store-within-a-store locations. Through this strategic alliance,
we generate revenues from sales to Rite Aid of our products at
wholesale prices, the manufacture of Rite Aid private label
products and retail sales of consignment inventory. We are Rite
Aids sole supplier for the PharmAssure vitamin brand and a
number of Rite Aid private label supplements. We recently
extended our alliance with Rite Aid through April 30, 2009,
with its commitment to open 300 new store-within-a-store
locations by December 31, 2006.
Distribution Agreement with
drugstore.com
We have an Internet distribution agreement with
drugstore.com, inc. Through this strategic alliance,
drugstore.com became the exclusive Internet retailer of our
proprietary products, the PharmAssure vitamin brand and certain
other nutritional supplements. The initial term of the agreement
expires in July 2009, subject to early termination provisions,
and the exclusivity period expires in June 2005. This alliance
allows us to access a larger customer base, who may not
otherwise live close to, or have the time to visit, a GNC store.
We generate revenues from the distribution agreement with
drugstore.com through sales of our proprietary and third-party
products on a wholesale basis and through retail sales of
certain other products on a consignment basis.
Our wholesale operations, including our Rite Aid
and drugstore.com wholesale operations, are supported by our
Anderson distribution center. Products are delivered to our
store-within-a-store locations in a manner similar to our
company-owned stores.
Research and Development
We have an internal research and development
group that performs scientific research on potential new and
existing products, in part to assist our product development
team in creating new products, and in part to support claims
that may be made as to the purpose and function of the product.
We incurred $0.8 million, $0.1 million,
$0.8 million, $1.4 million and $0.4 million in
our internal research and development for the six months ended
June 30, 2004, the 27 days ended December 31, 2003,
the period ended December 4, 2003, and the years ended
December 31, 2002 and 2001, respectively. Additionally,
prior to the Acquisition, Numico provided research and
development services and allocated costs to us of
$5.0 million, $4.6 million, and $4.9 million for
the period ended December 4, 2003, and the years ended
December 31, 2002 and 2001, respectively.
68
Revenue and Long Lived Assets by
Location
Revenue and long lived assets segregated by
location are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor
|
|
Successor
|
|
Predecessor
|
|
Successor
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twelve
|
|
Twelve
|
|
|
|
|
|
Six
|
|
Six
|
|
|
|
Months
|
|
Months
|
|
Period
|
|
27 Days
|
|
Months
|
|
Months
|
|
|
|
Ended
|
|
Ended
|
|
Ended
|
|
Ended
|
|
Ended
|
|
Ended
|
|
|
|
December 31,
|
|
December 31,
|
|
December 4,
|
|
December 31,
|
|
June 30,
|
|
June 30,
|
|
|
|
2001
|
|
2002
|
|
2003
|
|
2003
|
|
2003
|
|
2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
1,465.2
|
|
|
$
|
1,379.2
|
|
|
$
|
1,290.7
|
|
|
$
|
84.6
|
|
|
$
|
698.2
|
|
|
$
|
688.5
|
|
|
Canada
|
|
|
41.7
|
|
|
|
42.9
|
|
|
|
45.0
|
|
|
|
4.2
|
|
|
|
23.7
|
|
|
|
28.2
|
|
|
Other Foreign Countries
|
|
|
2.3
|
|
|
|
2.9
|
|
|
|
4.5
|
|
|
|
0.5
|
|
|
|
1.9
|
|
|
|
3.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International
|
|
|
44.0
|
|
|
|
45.8
|
|
|
|
49.5
|
|
|
|
4.7
|
|
|
|
25.0
|
|
|
|
31.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Revenue
|
|
$
|
1,509.2
|
|
|
$
|
1,425.0
|
|
|
$
|
1,340.2
|
|
|
$
|
89.3
|
|
|
$
|
723.2
|
|
|
$
|
720.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long Lived Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
2,591.9
|
|
|
$
|
1,287.5
|
|
|
$
|
498.9
|
|
|
$
|
555.6
|
|
|
$
|
1,282.1
|
|
|
$
|
583.2
|
|
|
Canada
|
|
|
6.5
|
|
|
|
6.7
|
|
|
|
6.4
|
|
|
|
6.5
|
|
|
|
7.3
|
|
|
|
5.0
|
|
|
Other Foreign Countries
|
|
|
5.3
|
|
|
|
4.5
|
|
|
|
1.0
|
|
|
|
4.7
|
|
|
|
0.9
|
|
|
|
0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International
|
|
|
11.8
|
|
|
|
11.2
|
|
|
|
7.4
|
|
|
|
11.2
|
|
|
|
8.2
|
|
|
|
5.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Long Lived Assets
|
|
$
|
2,603.7
|
|
|
$
|
1,298.7
|
|
|
$
|
506.3
|
|
|
$
|
566.8
|
|
|
$
|
1,290.3
|
|
|
$
|
589.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Competition
The U.S. nutritional supplements retail industry
is a large, highly fragmented and growing industry, with no
single industry participant accounting for more than 10% of
total industry retail sales. Competition is based primarily on
price, quality and assortment of products, customer service,
marketing support and availability of new products.
We compete with publicly owned and privately
owned companies, which are highly fragmented in terms of
geographical market coverage and product categories. We compete
with other specialty retailers, including Vitamin World and
Vitamin Shoppe®, supermarkets, drugstores, mass merchants,
multi-level marketing organizations, mail order companies and a
variety of other smaller participants. In addition, the market
is highly sensitive to the introduction of new products,
including various prescription drugs, which may rapidly capture
a significant share of the market. In the United States, we also
compete with supermarkets, drugstores and mass merchants with
heavily advertised national brands manufactured by large
pharmaceutical and food companies, as well as with the
Natures Bounty and Natures Wealth brands, sold by
Vitamin World and other retailers. Our international competitors
also include large international pharmacy chains and major
international supermarket chains as well as other large
U.S.-based companies with international operations. Our
wholesale and manufacturing operations also compete with other
wholesalers and manufacturers of third-party nutritional
supplements such as Tree of Life and Leiner Health Products.
Trademarks and Other Intellectual
Property
We believe trademark protection is particularly
important to the maintenance of the recognized brand names under
which we market our products. We own or have rights to material
trademarks or trade names that we use in conjunction with the
sale of our products, including the GNC brand name. We also rely
upon trade secrets, know-how, continuing technological
innovations and licensing opportunities to develop and maintain
our competitive position. We protect our intellectual property
rights through a variety of methods, including trademark, patent
and trade secret laws, as well as confidentiality agreements and
proprietary information agreements with vendors, employees,
consultants and others who have access to our proprietary
information. Protection of our intellectual property often
affords us the opportunity to enhance our position in
69
the marketplace by precluding our competitors
from using or otherwise exploiting our technology and brands. We
are also a party to several intellectual property license
agreements relating to certain of our products. For example,
several of our products are covered by patents which we license
from Numico. The scope and duration of our intellectual property
protection varies throughout the world by jurisdiction and by
individual product.
Insurance and Risk Management
We purchase insurance to cover standard risks in
the nutritional supplements industry, including policies to
cover general and products liability, workers compensation, auto
liability and other casualty and property risks. Our insurance
rates are based on our safety record as well as trends in the
insurance industry. We also maintain workers compensation
insurance and auto insurance policies that are retrospective in
that the cost per year will vary depending on the frequency and
severity of claims in the policy year. Prior to the Acquisition,
we were covered by certain of Numicos insurance policies.
Following the consummation of the Acquisition, we obtained our
own insurance policies to replace those policies that were
covered by Numico policies, including policies for general and
products liability. We currently maintain products liability
insurance with a deductible/retention of $1.0 million per
claim with an aggregate cap on retained losses of
$10.0 million, and general liability insurance with a
deductible/retention of $100,000 per occurrence with an
aggregate cap on retained losses of $600,000.
We face an inherent risk of exposure to product
liability claims in the event that, among other things, the use
of our products results in injury. With respect to product
liability coverage, we expect to carry insurance coverage
typical of our industry and product lines. Our coverage involves
self-insured retentions with primary and excess liability
coverage above the retention amount. We have the ability to
refer claims to our vendors and their insurers to pay the costs
associated with any claims arising from such vendors
products. Our insurance covers such claims that are not
adequately covered by a vendors insurance and provides for
excess secondary coverage above the limits provided by our
product vendors.
We self-insure certain property and casualty
risks due to our analysis of the risk, the frequency and
severity of a loss, and the cost of insurance for the risk. We
believe that the amount of self-insurance is not significant and
will not have an adverse impact on our performance.
Employees
As of June 30, 2004, we had a total of 5,249
full-time and 8,846 part-time employees, of whom approximately
12,249 were employed in our Retail segment; 39 were employed in
our Franchise segment; 1,266 were employed in our Manufacturing/
Wholesale segment; and 541 were employed in corporate support
functions. None of our employees belongs to a union or is a
party to any collective bargaining or similar agreement. We
consider our relationships with our employees to be good.
Properties
In our Retail segment, there were 2,649
company-owned stores operating in the United States and Canada
as of June 30, 2004. All but one of our stores are located
on leased premises that typically range in size from 1,000 to
2,000 square feet. In our Franchise segment, substantially all
of our 1,331 franchised stores in the United States and Canada
are located on premises we lease, and then sublease to our
respective franchisees. All of our 692 franchised stores in
other international locations are owned or leased directly by
our franchisees. No single store is material to our operations.
As of June 30, 2004, our company-owned and
franchised stores in the United States and Canada (excluding
store-within-a-store locations) and our other international
franchised stores consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company-
|
|
|
|
|
|
|
|
|
|
Owned
|
|
|
|
|
|
|
|
United States and Canada
|
|
Retail
|
|
Franchise
|
|
Other International
|
|
Franchise
|
|
|
|
|
|
|
|
|
|
|
Alabama
|
|
|
32
|
|
|
|
14
|
|
|
|
Aruba
|
|
|
|
2
|
|
|
Alaska
|
|
|
6
|
|
|
|
5
|
|
|
|
Australia
|
|
|
|
35
|
|
|
Arizona
|
|
|
45
|
|
|
|
15
|
|
|
|
Bahamas
|
|
|
|
3
|
|
70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company-
|
|
|
|
|
|
|
|
|
|
Owned
|
|
|
|
|
|
|
|
United States and Canada
|
|
Retail
|
|
Franchise
|
|
Other International
|
|
Franchise
|
|
|
|
|
|
|
|
|
|
|
Arkansas
|
|
|
18
|
|
|
|
6
|
|
|
|
Brazil
|
|
|
|
15
|
|
|
California
|
|
|
202
|
|
|
|
182
|
|
|
|
Brunei
|
|
|
|
1
|
|
|
Colorado
|
|
|
47
|
|
|
|
29
|
|
|
Cayman Islands
|
|
|
1
|
|
|
Connecticut
|
|
|
38
|
|
|
|
8
|
|
|
|
Chile
|
|
|
|
47
|
|
|
Delaware
|
|
|
8
|
|
|
|
10
|
|
|
|
China
|
|
|
|
1
|
|
|
District of Columbia
|
|
|
6
|
|
|
|
2
|
|
|
|
Columbia
|
|
|
|
1
|
|
|
Florida
|
|
|
220
|
|
|
|
120
|
|
|
Costa Rica
|
|
|
5
|
|
|
Georgia
|
|
|
88
|
|
|
|
63
|
|
|
Dominican Republic
|
|
|
12
|
|
|
Hawaii
|
|
|
20
|
|
|
|
1
|
|
|
|
Ecuador
|
|
|
|
14
|
|
|
Idaho
|
|
|
9
|
|
|
|
5
|
|
|
El Salvador
|
|
|
8
|
|
|
Illinois
|
|
|
85
|
|
|
|
76
|
|
|
|
Guam
|
|
|
|
3
|
|
|
Indiana
|
|
|
48
|
|
|
|
35
|
|
|
|
Guatemala
|
|
|
|
12
|
|
|
Iowa
|
|
|
23
|
|
|
|
11
|
|
|
|
Honduras
|
|
|
|
1
|
|
|
Kansas
|
|
|
19
|
|
|
|
14
|
|
|
Hong Kong
|
|
|
10
|
|
|
Kentucky
|
|
|
36
|
|
|
|
11
|
|
|
|
Indonesia
|
|
|
|
24
|
|
|
Louisiana
|
|
|
39
|
|
|
|
7
|
|
|
|
Israel
|
|
|
|
16
|
|
|
Maine
|
|
|
9
|
|
|
|
0
|
|
|
|
Japan
|
|
|
|
8
|
|
|
Maryland
|
|
|
55
|
|
|
|
29
|
|
|
|
Kuwait
|
|
|
|
4
|
|
|
Massachusetts
|
|
|
54
|
|
|
|
12
|
|
|
|
Lebanon
|
|
|
|
5
|
|
|
Michigan
|
|
|
78
|
|
|
|
49
|
|
|
|
Malaysia
|
|
|
|
18
|
|
|
Minnesota
|
|
|
60
|
|
|
|
16
|
|
|
|
Mexico
|
|
|
|
167
|
|
|
Mississippi
|
|
|
20
|
|
|
|
8
|
|
|
|
Pakistan
|
|
|
|
1
|
|
|
Missouri
|
|
|
44
|
|
|
|
21
|
|
|
|
Panama
|
|
|
|
5
|
|
|
Montana
|
|
|
4
|
|
|
|
3
|
|
|
|
Peru
|
|
|
|
13
|
|
|
Nebraska
|
|
|
6
|
|
|
|
18
|
|
|
|
Philippines
|
|
|
|
42
|
|
|
Nevada
|
|
|
12
|
|
|
|
10
|
|
|
Saudi Arabia
|
|
|
35
|
|
|
New Hampshire
|
|
|
17
|
|
|
|
5
|
|
|
|
Singapore
|
|
|
|
62
|
|
|
New Jersey
|
|
|
72
|
|
|
|
59
|
|
|
South Africa
|
|
|
8
|
|
|
New Mexico
|
|
|
21
|
|
|
|
2
|
|
|
South Korea
|
|
|
18
|
|
|
New York
|
|
|
148
|
|
|
|
60
|
|
|
|
Taiwan
|
|
|
|
14
|
|
|
North Carolina
|
|
|
83
|
|
|
|
48
|
|
|
|
Thailand
|
|
|
|
29
|
|
|
North Dakota
|
|
|
6
|
|
|
|
0
|
|
|
|
Turkey
|
|
|
|
20
|
|
|
Ohio
|
|
|
103
|
|
|
|
66
|
|
|
U.S. Virgin Islands
|
|
|
2
|
|
|
Oklahoma
|
|
|
31
|
|
|
|
7
|
|
|
|
Venezuela
|
|
|
|
30
|
|
|
Oregon
|
|
|
22
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
Pennsylvania
|
|
|
134
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
Puerto Rico
|
|
|
25
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
Rhode Island
|
|
|
12
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
South Carolina
|
|
|
28
|
|
|
|
27
|
|
|
|
|
|
|
|
|
|
|
South Dakota
|
|
|
5
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
Tennessee
|
|
|
42
|
|
|
|
36
|
|
|
|
|
|
|
|
|
|
|
Texas
|
|
|
203
|
|
|
|
91
|
|
|
|
|
|
|
|
|
|
|
Utah
|
|
|
23
|
|
|
|
8
|
|
|
|
|
|
|
|
|
|
|
Vermont
|
|
|
5
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
Virginia
|
|
|
81
|
|
|
|
31
|
|
|
|
|
|
|
|
|
|
|
Washington
|
|
|
48
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
West Virginia
|
|
|
25
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
Wisconsin
|
|
|
47
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
Wyoming
|
|
|
4
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
Canada
|
|
|
134
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,649
|
|
|
|
1,331
|
|
|
|
Total
|
|
|
|
692
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In our Manufacturing/ Wholesale segment, we lease
facilities for manufacturing, packaging, warehousing, and
distribution operations. We manufacture a majority of our
proprietary products at a 230,000 square foot facility in
Greenville, South Carolina. We also lease a 630,000 square foot
complex located in Anderson, South Carolina, for packaging,
materials receipt, lab testing, warehousing, and distribution.
Both the Greenville and Anderson facilities are leased on a
long-term basis pursuant to fee-in-lieu-of-taxes
arrangements with the counties in which the facilities are
located, but we retain the right to purchase each of the
facilities at any time during the lease for $1.00, subject to a
loss of tax benefits. We also lease a 210,000
71
square foot distribution center in Leetsdale,
Pennsylvania and a 112,000 square foot distribution center in
Phoenix, Arizona. We conduct additional manufacturing for
wholesalers and retailers of third-party products as well as
warehouse certain third-party products at a leased facility
located in New South Wales, Australia.
We also lease four small regional sales offices
in Clearwater, Florida; Fort Lauderdale, Florida; Laguna Hills,
California; and Mississauga, Ontario. None of the regional sales
offices is larger than 5,000 square feet. Our 253,000 square
foot corporate headquarters in Pittsburgh, Pennsylvania is owned
by Gustine Sixth Avenue Associates, Ltd., a Pennsylvania limited
partnership, of which General Nutrition, Incorporated, one of
our subsidiaries, is a 50% limited partner. The
partnerships ownership of the land and buildings, and the
partnerships interest in the ground lease to General
Nutrition, Incorporated, are all encumbered by a mortgage in the
original principal amount of $17.9 million, with an
outstanding balance of $13.7 million as of June 30,
2004.
Environmental
We are subject to numerous federal, state, local
and foreign environmental laws and regulations governing our
operations, including the handling, transportation and disposal
of our products, and our non-hazardous and hazardous substances
and wastes, as well as emissions and discharges into the
environment, including discharges to air, surface water and
groundwater. Failure to comply with such laws and regulations
could result in costs for corrective action, penalties or the
imposition of other liabilities. Changes in laws or the
interpretation thereof or the development of new facts could
also cause us to incur additional capital and operation
expenditures to maintain compliance with environmental laws and
regulations. We also are subject to laws and regulations that
impose liability and cleanup responsibility for releases of
hazardous substances into the environment without regard to
fault or knowledge about the condition or action causing the
liability. Under certain of these laws and regulations, such
liabilities can be imposed for cleanup of previously owned or
operated properties, or properties to which substances or wastes
were sent by current or former operations at our facilities. The
presence of contamination from such substances or wastes could
also adversely affect our ability to sell or lease our
properties, or to use them as collateral for financing. From
time to time, we have incurred and are incurring costs and
obligations for correcting environmental noncompliance matters
and for remediation at or relating to certain of our properties.
We believe we have complied with, or are currently complying
with, our environmental obligations to date and that such
liabilities will not have a material adverse effect on our
business or financial performance. However, it is difficult to
predict future liabilities and obligations which could be
material.
Legal Proceedings
We are from time to time engaged in litigation.
We regularly review all pending litigation matters in which we
are involved and establish reserves deemed appropriate by
management for these litigation matters. However, some of these
matters are material and an adverse outcome in these matters
could have a material impact on our financial condition and
operating results.
As a manufacturer and retailer of nutritional
supplements and other consumer products that are ingested by
consumers or applied to their bodies, we have been and are
currently subjected to various product liability claims.
Although the effects of these claims to date have not been
material to us, it is possible that current and future product
liability claims could have a material adverse impact on our
financial condition and operating results. We currently maintain
product liability insurance with a deductible/retention of
$1.0 million per claim with an aggregate cap on retained
loss of $10 million per claim. We typically seek and have
obtained contractual indemnification from substantially all
parties that supply raw materials for our products or that
manufacture or market products we sell. We also typically seek
to be added, and have been added, as additional insured under
most of such parties insurance policies. We are also
entitled to indemnification by Numico for certain losses arising
from claims related to products containing ephedra or Kava Kava
sold prior to December 5, 2003. However, any such
indemnification or insurance is limited by its terms and any
such indemnification, as a practical matter, is limited to the
creditworthiness of the indemnifying party and its insurer, and
the absence of significant defenses by the insurers. See
Risk Factor Risks Relating to Our
72
Business and Industry We may incur
material products liability claims, which could increase our
costs and adversely affect our reputation, revenues and
operating income.
Ephedra (Ephedrine Alkaloids).
As of August 4, 2004, we have been
named as a defendant in 137 pending cases involving the sale of
third-party products that contain ephedra. Ephedra products have
been the subject of adverse publicity and regulatory scrutiny in
the United States and other countries relating to alleged
harmful effects, including the deaths of several individuals. In
early 2003, we instructed all of our locations to stop selling
products containing ephedra that were manufactured by GNC or one
of our affiliates. Subsequently, we instructed all of our
locations to stop selling any products containing ephedra by
June 30, 2003. In April 2004, the FDA banned the sale of
products containing ephedra. All claims to date have been
tendered to the third-party manufacturer or to our insurer and
we have incurred no expense to date with respect to litigation
involving ephedra products. Furthermore, we are entitled to
indemnification by Numico for certain losses arising from claims
related to products containing ephedra sold prior to
December 5, 2003. All of the pending cases relate to
products sold prior to such time and, accordingly, we are
entitled to indemnification from Numico for all of the pending
cases.
Pro-Hormone/ Androstenedione.
On July 29, 2001, five
substantially identical class action lawsuits were filed in the
state courts of the States of Florida, New York, New Jersey,
Pennsylvania and Illinois against us and various manufacturers
of products containing pro-hormones, including androstenedione:
|
|
|
|
|
|
|
Brown v. General Nutrition Companies, Inc.,
Case No. 02-14221-AB, Florida Circuit
Court for the 15th Judicial Circuit Court, Palm Beach County;
|
|
|
|
|
|
Rodriguez v. General Nutrition Companies,
Inc.,
Index No. 02/126277, New York
Supreme Court, County of New York, Commercial Division;
|
|
|
|
|
|
Abrams v. General Nutrition Companies,
Inc.,
Docket No. L-3789-02, New Jersey
Superior Court, Mercer County;
|
|
|
|
|
|
Toth v. Bodyonics, Ltd.,
Case No. 003886, Pennsylvania Court of
Common Pleas, Philadelphia County; and
|
|
|
|
|
|
Pio v. General Nutrition Companies, Inc.,
Case No. 2-CH-14122, Illinois Circuit
Court, Cook County.
|
On March 20, 2004, a similar lawsuit was filed in
California
(Guzman v. General Nutrition Companies, Inc.,
Case No. 04-00283). Plaintiffs allege that we have
distributed or published periodicals that contain advertisements
claiming that the various pro-hormone products promote muscle
growth. The complaint alleges that we knew the advertisements
and label claims promoting muscle growth were false, but
nonetheless continued to sell the products to consumers.
Plaintiffs seek injunctive relief, disgorgement of profits,
attorneys fees and the costs of suit. We have tendered
these cases to the various manufacturers for defense and
indemnification. Based upon the information available to us at
the present time, we believe that these matters will not have a
material adverse effect upon our liquidity, financial condition
or results of operations.
California Wage
Claim.
On November 2, 2001,
Matthew Capelouto, a former store manager in California, filed a
putative class action lawsuit in the Superior Court of
California, Orange County
(Capelouto v. General Nutrition
Corporation,
Case No. 01-CC-00138). The lawsuit alleges that
we misclassified store managers at our company-owned stores in
California as exempt from overtime requirements and/or required
them to work off the clock, and failed to pay them overtime, in
violation of Californias wage and hour laws. On
October 23, 2003, an amended complaint was filed, adding
another named plaintiff, Lamar Wright, as well as claims for
failure to provide required meal periods and rest periods for
GNC managers at company-owned stores in California. The
plaintiff seeks compensatory damages with interest, disgorgement
of profits, punitive damages, meal period and rest period
compensation, attorneys fees and the costs of suit. On
May 13, 2004, we entered into an agreement in principle to
settle the claims of the putative class members, without
admitting any liability, for a total payment of approximately
$4.6 million, inclusive of class counsels attorneys
fees, costs and expenses, plus up to $20,000 of the costs of
settlement administration. The settlement is subject to approval
by the court and the plaintiffs class. Moreover, we have
the right to rescind the settlement if more than 10% of the
putative class members opt out of the settlement.
73
Wage and Hour Claim.
On or about May 10, 2004, seven former employees brought an
action in the United States District Court for the Southern
District of New York on behalf of themselves and a purported
class of other similarly situated former employees employed by
GNC within the last six years and who allegedly worked but were
not paid overtime for hours worked in excess of 40 hours per
week
(Shockley v. General Nutrition Corporation,
Case No.
04-CIV-2336). The complaint is brought under the federal Fair
Labor Standards Act and New York State Labor Law. The plaintiffs
seek actual damages, liquidated damages on claims asserted under
the FLSA, an order enjoining GNC from engaging in the practices
alleged in their complaint, and attorneys fees and the
costs of suit. Based on the information available to us at the
present time, we believe that this matter will not have a
material adverse effect upon our liquidity, financial condition
or results of operations.
Government Regulation
Product Regulation
Domestic
The processing, formulation, manufacturing,
packaging, labeling, advertising and distribution of our
products are subject to regulation by several federal agencies,
including the Food and Drug Administration (FDA),
the Federal Trade Commission (FTC), the Consumer
Product Safety Commission, the United States Department of
Agriculture and the Environmental Protection Agency. These
activities are also regulated by various agencies of the states
and localities in which our products are sold. Pursuant to the
Federal Food, Drug, and Cosmetic Act (FDCA), the FDA
regulates the processing, formulation, safety, manufacture,
packaging, labeling and distribution of dietary supplements,
(including vitamins, minerals, herbs) and over-the-counter
drugs. The FTC has jurisdiction to regulate the advertising of
these products.
The FDCA has been amended several times with
respect to dietary supplements, in particular by the Dietary
Supplement Health and Education Act of 1994 (DSHEA).
DSHEA established a new framework governing the composition,
safety, labeling and marketing of dietary supplements.
Dietary supplements are defined as vitamins,
minerals, herbs, other botanicals, amino acids and other dietary
substances for human use to supplement the diet, as well as
concentrates, metabolites, constituents, extracts or
combinations of such dietary ingredients. Generally, under
DSHEA, dietary ingredients that were on the market prior to
October 15, 1994 may be used in dietary supplements without
notifying the FDA. New dietary ingredients (i.e.,
dietary ingredients that were not marketed in the United
States before October 15, 1994) must be the subject
of a new dietary ingredient notification submitted to the FDA
unless the ingredient has been present in the food supply
as an article used for food without being chemically
altered. A new dietary ingredient notification must
provide the FDA evidence of a history of use or other
evidence of safety establishing that use of the dietary
ingredient will reasonably be expected to be safe. A
new dietary ingredient notification must be submitted to the FDA
at least 75 days before the initial marketing of the new
dietary ingredient. There is no certainty that the FDA will
accept any particular evidence of safety for any new dietary
ingredient. The FDAs refusal to accept such evidence could
prevent the marketing of such dietary ingredients.
The FDA issued a consumer warning in 1996,
followed by proposed regulations in 1997, covering dietary
supplements that contain ephedra or its active substance,
ephedrine alkaloids. In February 2003, the Department of Health
and Human Services, announced a series of actions that the
Department of Health and Human Services and the FDA plan to
execute with respect to products containing ephedra, including
the solicitation of evidence regarding the significant or
unreasonable risk of illness or injury from dietary supplements
containing ephedra and the immediate execution of a series of
actions against ephedra making unsubstantiated claims about
sports performance enhancement. In addition, many states
proposed regulations and three states enacted laws restricting
the promotion and distribution of ephedra- containing dietary
supplements. The botanical ingredient ephedra was formerly used
in several third party and private label dietary supplement
products. In January 2003, we began focusing our diet category
on products that would replace ephedra products. In early 2003,
we instructed all of our locations to stop selling products
containing ephedra that were manufactured by GNC or one of our
affiliates. Subsequently, we instructed all of our
74
locations to stop selling any products containing
ephedra by June 30, 2003. Sales of products containing
ephedra amounted to approximately $35.2 million, or 3.3% of
our retail sales, in 2003 and approximately $182.9 million,
or 17.1% of our retail sales, in 2002. In February 2004, the FDA
issued a final regulation declaring dietary supplements
containing ephedra illegal under the FDCA because they present
an unreasonable risk of illness or injury under the conditions
of use recommended or suggested in labeling, or if no conditions
of use are suggested or recommended in labeling, under ordinary
conditions of use. The rule took effect on April 12, 2004
and bans the sale of dietary supplement products containing
ephedra. Similarly, the FDA issued a consumer advisory in 2002
with respect to dietary supplements that contain the ingredient
Kava, and the FDA is currently investigating adverse effects
associated with ingestion of this ingredient. One of our
subsidiaries, Nutra Manufacturing, Inc. (f/k/a Nutricia
Manufacturing USA, Inc.), manufactured products containing Kava
Kava from December 1995 until August 2002. All stores were
instructed to stop selling products containing Kava Kava in
December 2002. The FDA could take similar actions against other
products or product ingredients which it determines present an
unreasonable health risk to consumers.
DSHEA permits statements of nutritional
support to be included in labeling for dietary supplements
without FDA premarket approval. Such statements must be
submitted to FDA within 30 days of marketing and must bear
a label disclosure that This statement has not been
evaluated by the Food and Drug Administration. This product is
not intended to diagnose, treat, cure, or prevent any
disease. Such statements may describe how a particular
dietary ingredient affects the structure, function or general
well-being of the body, or the mechanism of action by which a
dietary ingredient may affect body structure, function or
well-being, but may not expressly or implicitly represent that a
dietary supplement will diagnose, cure, mitigate, treat, or
prevent a disease. A company that uses a statement of
nutritional support in labeling must possess scientific evidence
substantiating that the statement is truthful and not
misleading. If the FDA determines that a particular statement of
nutritional support is an unacceptable drug claim or an
unauthorized version of a disease claim for a food product, or
if the FDA determines that a particular claim is not adequately
supported by existing scientific data or is false or misleading,
we would be prevented from using the claim.
In addition, DSHEA provides that so-called
third-party literature, e.g., a reprint of a
peer-reviewed scientific publication linking a particular
dietary ingredient with health benefits, may be used in
connection with the sale of a dietary supplement to
consumers without the literature being subject to
regulation as labeling. Such literature must not be false or
misleading; the literature may not promote a
particular manufacturer or brand of dietary supplement; and a
balanced view of the available scientific information on the
subject matter must be presented. If the literature fails to
satisfy each of these requirements, we may be prevented from
disseminating such literature with our products, and any
dissemination could subject our product to regulatory action as
an illegal drug.
We expect that the FDA will adopt in the near
future the final regulations, proposed on March 13, 2003,
regarding Good Manufacturing Practice in manufacturing, packing,
or holding dietary ingredients and dietary supplements,
authorized by DSHEA. Good Manufacturing Practice regulations
will require dietary supplements to be prepared, packaged and
held in compliance with strict rules, and will require quality
control provisions similar to those in the Good Manufacturing
Practice regulations for drugs. We or our third-party supplier
or vendors may not be able to comply with the new rules without
incurring substantial additional expenses. In addition, if our
third-party suppliers or vendors are not able to timely comply
with the new rules, we may experience increased costs or delays
in obtaining certain raw materials and third-party products.
The FDA has broad authority to enforce the
provisions of the FDCA applicable to dietary supplements,
including powers to issue a public warning letter to a company,
to publicize information about illegal products, to request a
recall of illegal products from the market, and to request the
Department of Justice to initiate a seizure action, an
injunction action, or a criminal prosecution in the United
States courts. The regulation of dietary supplements may
increase or become more restrictive in the future.
Legislation has been introduced in Congress to
impose substantial new regulatory requirements for dietary
supplements, e.g., S.722, S.1538, S.1780, H.R. 3377 and
H.R. 3866. S.722 would impose adverse event reporting,
postmarket surveillance requirements, FDA reviews of dietary
supplement ingredients, and
75
other requirements. H.R. 3377 would impose
similar requirements as well as safety testing and records
inspection. S.1538 would increase FDA appropriations to allow
full implementation and enforcement of DSHEA. S.1780 and
H.R. 3866 would subject specified anabolic steroid
substances currently used in some dietary supplements, such as
andro, to the requirements of the Controlled
Substances Act. The dietary supplement industry supports S.1538,
S.1780, and H.R. 3866. Key members of Congress and the
dietary supplement industry have indicated that they have
reached agreement to support legislation requiring adverse event
reporting. If enacted, S.722 and H.R. 3377 could raise our costs
and hinder our business.
The FTC exercises jurisdiction over the
advertising of dietary supplements. In recent years, the FTC has
instituted numerous enforcement actions against dietary
supplement companies for failure to have adequate substantiation
for claims made in advertising or for the use of false or
misleading advertising claims. We continue to be subject to
three consent orders issued by the FTC. In 1984, the FTC
instituted an investigation of General Nutrition, Incorporated,
one of our subsidiaries, alleging deceptive acts and practices
in connection with the advertising and marketing of certain of
its products. General Nutrition, Incorporated accepted a
proposed consent order which was finalized in 1989, under which
it agreed to refrain from, among other things, making certain
claims with respect to certain of its products unless the claims
are based on and substantiated by reliable and competent
scientific evidence. We also entered into a consent order in
1970 with the FTC, which generally addressed iron
deficiency anemia type products. As a result of routine
monitoring by the FTC, disputes arose concerning its compliance
with these orders, and with regard to advertising for certain
hair care products. While General Nutrition, Incorporated
believes that, at all times, it operated in material compliance
with the orders, it entered into a settlement in 1994 with the
FTC to avoid protracted litigation. As a part of this
settlement, General Nutrition, Incorporated entered into a
consent decree and paid, without admitting liability, a civil
penalty in the amount of $2.4 million and agreed to adhere
to the terms of the 1970 and 1989 consent orders and to abide by
the provisions of the settlement document concerning hair care
products. We do not believe that future compliance with the
outstanding consent decrees will materially affect our business
operations. In 2000, the FTC amended the 1970 order to clarify
language in the 1970 order that was believed to be ambiguous and
outmoded.
The FTC continues to monitor our advertising and,
from time to time, requests substantiation with respect to such
advertising to assess compliance with the various outstanding
consent decrees and with the Federal Trade Commission Act. Our
policy is to use advertising that complies with the consent
decrees and applicable regulations. We review all products
brought into our distribution centers to assure that such
products and their labels comply with the consent decrees. We
also review the use of third-party point of purchase materials
such as store signs and promotional brochures. Nevertheless,
there can be no assurance that inadvertent failures to comply
with the consent decrees and applicable regulations will not
occur. Approximately 20% of the products sold by franchised
stores are purchased by franchisees directly from other vendors
and these products do not flow through our distribution centers.
Although franchise contracts contain strict requirements for
store operations, including compliance with federal, state, and
local laws and regulations, we cannot exercise the same degree
of control over franchisees as we do over our company-owned
stores. As a result of our efforts to comply with applicable
statutes and regulations, we have from time to time
reformulated, eliminated or relabeled certain of our products
and revised certain provisions of our sales and marketing
program. We believe we are in material compliance with the
various consent decrees and with applicable federal, state and
local rules and regulations concerning our products and
marketing program. Compliance with the provisions of national,
state and local environmental laws and regulations has not had a
material effect upon our capital expenditures, earnings,
financial position, liquidity or competitive position.
Foreign
Our products sold in foreign countries are also
subject to regulation under various national, local, and
international laws that include provisions governing, among
other things, the processing, formulation, manufacturing,
packaging, labeling, advertising and distribution of dietary
supplements and over-the-counter drugs. Government regulations
in foreign countries may prevent or delay the introduction, or
require the reformulation, of certain of our products.
76
We cannot determine what effect additional
domestic or international governmental legislation, regulations
or administrative orders, when and if promulgated, would have on
our business in the future. New legislation or regulations may
require the reformulation of certain products to meet new
standards, require the recall or discontinuance of certain
products not capable of reformulation, impose additional record
keeping or require expanded documentation of the properties of
certain products, expanded or different labeling, or scientific
substantiation.
Franchise Regulation
We must comply with regulations adopted by the
FTC and with several state laws that regulate the offer and sale
of franchises. The FTCs Trade Regulation Rule on
Franchising and certain state laws require that we furnish
prospective franchisees with a franchise offering circular
containing information prescribed by the Trade
Regulation Rule on Franchising and applicable state laws
and regulations.
We also must comply with a number of state laws
that regulate some substantive aspects of the
franchisor-franchisee relationship. These laws may limit a
franchisors business practices in a number of ways,
including limiting the ability to:
|
|
|
|
|
|
|
terminate or not renew a franchise without good
cause;
|
|
|
|
|
|
interfere with the right of free association
among franchisees;
|
|
|
|
|
|
disapprove the transfer of a franchise;
|
|
|
|
|
|
discriminate among franchisees with regard to
charges, royalties and other fees; and
|
|
|
|
|
|
place new stores near existing franchises.
|
To date, these laws have not precluded us from
seeking franchisees in any given area and have not had a
material adverse effect on our operations. Bills intended to
regulate certain aspects of franchise relationships have been
introduced into Congress on several occasions during the last
decade, but none have been enacted.
Our international franchise agreements and
franchise operations are regulated by various foreign laws,
rules and regulations. To date, these laws have not precluded us
from seeking franchisees in any given area and have not had a
material adverse effect on our operations.
77
|
|